Tags

Type your tag names separated by a space and hit enter

[A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS].
Zhonghua Nei Ke Za Zhi. 2006 Nov; 45(11):896-9.ZN

Abstract

OBJECTIVE

To survey the dynamic changing and persistence of the special antibodies, including total IgM, IgG, nucleocapsid protein and spike protein antibodies, against severe acute respiratory syndrome coronavirus (SARS-CoV) in patients with SARS.

METHODS

146 cases, all clinically diagnosed as SARS with positive SARS-CoV IgG, were followed up. 362 serum samples were collected from the onset of the disease to 660 days afterward. Total IgM and IgG against SARS-CoV were tested with commercial ELISA kits. For recombinant nucleoprotein and spike protein, we developed an ELISA to test these two antibodies.

RESULTS

Within 20 days of the onset, the positive rate of anti-SARS-CoV IgM was 46.5% (20/43); it reached a peak after 21 - 40 days (80.6%, 25/31). Then, the positive rate of IgM went down gradually to 8.2% (6/73) until 550 days after the onset. The patient's IgG positive rate was lower (34.9%, 15/43) than that of IgM within 20 days of the onset. Then it went up rapidly to 100%. It remained positive (98.6%, 70/71) until 600 - 660 days after the onset. When N-IgG and S-IgG were tested 40 days after the onset of the disease at three different times, the positive rate of N-IgG (92.5%, 37/40) was higher than that of S-IgG (67.5%, 27/40), but the two structure protein antibodies were always lower than the total IgG.

CONCLUSIONS

In SARS patients with definite clinical and etiological diagnosis, the highest positive rate of the antibodies against SARS-CoV was found at 21 - 40 days after the onset. IgM disappeared almost 500 days (91.8%) after the onset. Total IgG positive rate could reach 100% and 98.6% and the positivity might persist nearly two years. So it is speculated that the total IgG antibody may be positive 3 to 5 years after infection, but it seems that N-IgG and S-IgG keep positive shorter in time than total IgG antibody.

Authors+Show Affiliations

Central Laboratory of Infectious Diseases, Beijing Youan Hospital, Capital University of Medical Sciences, Beijing 100069, China. yhp503@vip.sina.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

17313874

Citation

Yan, Hui-ping, et al. "[A Follow Up Study of Total IgM, IgG, Nucleoprotein and Spike Protein Antibodies Against Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients With SARS]." Zhonghua Nei Ke Za Zhi, vol. 45, no. 11, 2006, pp. 896-9.
Yan HP, Tan YF, Zhuang H, et al. [A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS]. Zhonghua Nei Ke Za Zhi. 2006;45(11):896-9.
Yan, H. P., Tan, Y. F., Zhuang, H., Zhou, Y. S., Zhao, C. H., Feng, X., Jin, R. H., Wu, H., & Fu, Y. (2006). [A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS]. Zhonghua Nei Ke Za Zhi, 45(11), 896-9.
Yan HP, et al. [A Follow Up Study of Total IgM, IgG, Nucleoprotein and Spike Protein Antibodies Against Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients With SARS]. Zhonghua Nei Ke Za Zhi. 2006;45(11):896-9. PubMed PMID: 17313874.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS]. AU - Yan,Hui-ping, AU - Tan,Yu-fen, AU - Zhuang,Hui, AU - Zhou,Yu-sen, AU - Zhao,Chun-hui, AU - Feng,Xia, AU - Jin,Rong-hua, AU - Wu,Hao, AU - Fu,Yan, PY - 2007/2/23/pubmed PY - 2007/6/23/medline PY - 2007/2/23/entrez SP - 896 EP - 9 JF - Zhonghua nei ke za zhi JO - Zhonghua Nei Ke Za Zhi VL - 45 IS - 11 N2 - OBJECTIVE: To survey the dynamic changing and persistence of the special antibodies, including total IgM, IgG, nucleocapsid protein and spike protein antibodies, against severe acute respiratory syndrome coronavirus (SARS-CoV) in patients with SARS. METHODS: 146 cases, all clinically diagnosed as SARS with positive SARS-CoV IgG, were followed up. 362 serum samples were collected from the onset of the disease to 660 days afterward. Total IgM and IgG against SARS-CoV were tested with commercial ELISA kits. For recombinant nucleoprotein and spike protein, we developed an ELISA to test these two antibodies. RESULTS: Within 20 days of the onset, the positive rate of anti-SARS-CoV IgM was 46.5% (20/43); it reached a peak after 21 - 40 days (80.6%, 25/31). Then, the positive rate of IgM went down gradually to 8.2% (6/73) until 550 days after the onset. The patient's IgG positive rate was lower (34.9%, 15/43) than that of IgM within 20 days of the onset. Then it went up rapidly to 100%. It remained positive (98.6%, 70/71) until 600 - 660 days after the onset. When N-IgG and S-IgG were tested 40 days after the onset of the disease at three different times, the positive rate of N-IgG (92.5%, 37/40) was higher than that of S-IgG (67.5%, 27/40), but the two structure protein antibodies were always lower than the total IgG. CONCLUSIONS: In SARS patients with definite clinical and etiological diagnosis, the highest positive rate of the antibodies against SARS-CoV was found at 21 - 40 days after the onset. IgM disappeared almost 500 days (91.8%) after the onset. Total IgG positive rate could reach 100% and 98.6% and the positivity might persist nearly two years. So it is speculated that the total IgG antibody may be positive 3 to 5 years after infection, but it seems that N-IgG and S-IgG keep positive shorter in time than total IgG antibody. SN - 0578-1426 UR - https://www.unboundmedicine.com/medline/citation/17313874/[A_follow_up_study_of_total_IgM_IgG_nucleoprotein_and_spike_protein_antibodies_against_severe_acute_respiratory_syndrome__SARS__coronavirus_in_patients_with_SARS]_ DB - PRIME DP - Unbound Medicine ER -